Calumet Specialty Products Partners, L.P. Logo

Calumet Specialty Products Partners, L.P.

CLMT

(2.2)
Stock Price

21,87 USD

-0.86% ROA

5.15% ROE

-70.96x PER

Market Cap.

1.740.206.362,00 USD

-370.62% DER

0% Yield

-0.45% NPM

Calumet Specialty Products Partners, L.P. Stock Analysis

Calumet Specialty Products Partners, L.P. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Calumet Specialty Products Partners, L.P. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (40.3%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

With a remarkably low PBV ratio (-142.03x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a minimal amount of debt (-22515%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Revenue Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

5 Net Profit Growth

With continuous net profit growth in the past three years, this company demonstrates a strong financial performance, making it an enticing investment opportunity.

6 Assets Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

7 ROA

The stock's ROA (-2.13%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

8 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

The company's stock appears overvalued (-1.591) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Calumet Specialty Products Partners, L.P. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Calumet Specialty Products Partners, L.P. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Calumet Specialty Products Partners, L.P. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Calumet Specialty Products Partners, L.P. Revenue
Year Revenue Growth
2001 306.760.000
2002 316.350.000 3.03%
2003 430.381.000 26.5%
2004 539.616.000 20.24%
2005 1.289.072.000 58.14%
2006 1.641.048.000 21.45%
2007 1.637.848.000 -0.2%
2008 2.488.994.000 34.2%
2009 1.846.600.000 -34.79%
2010 2.190.752.000 15.71%
2011 3.134.923.000 30.12%
2012 4.657.282.000 32.69%
2013 5.421.400.000 14.09%
2014 5.791.100.000 6.38%
2015 4.212.800.000 -37.46%
2016 3.599.400.000 -17.04%
2017 3.763.800.000 4.37%
2018 3.497.500.000 -7.61%
2019 3.452.600.000 -1.3%
2020 2.268.200.000 -52.22%
2021 3.148.000.000 27.95%
2022 4.686.700.000 32.83%
2023 8.148.800.000 42.49%
2023 4.181.000.000 -94.9%
2024 4.534.800.000 7.8%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Calumet Specialty Products Partners, L.P. Research and Development Expenses
Year Research and Development Expenses Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Calumet Specialty Products Partners, L.P. General and Administrative Expenses
Year General and Administrative Expenses Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 32.570.000 100%
2010 35.224.000 7.53%
2011 50.836.000 30.71%
2012 168.804.000 69.88%
2013 224.800.000 24.91%
2014 269.700.000 16.65%
2015 311.000.000 13.28%
2016 279.800.000 -11.15%
2017 275.800.000 -1.45%
2018 259.700.000 -6.2%
2019 259.600.000 -0.04%
2020 202.100.000 -28.45%
2021 151.100.000 -33.75%
2022 141.000.000 -7.16%
2023 160.800.000 12.31%
2023 133.000.000 -20.9%
2024 150.000.000 11.33%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Calumet Specialty Products Partners, L.P. EBITDA
Year EBITDA Growth
2001 -11.263.000
2002 5.540.000 303.3%
2003 -9.770.000 156.7%
2004 -35.244.000 72.28%
2005 112.133.000 131.43%
2006 154.544.000 27.44%
2007 295.769.000 47.75%
2008 240.965.000 -22.74%
2009 140.193.000 -71.88%
2010 135.641.000 -3.36%
2011 199.685.000 32.07%
2012 378.067.000 47.18%
2013 212.100.000 -78.25%
2014 219.100.000 3.19%
2015 194.300.000 -12.76%
2016 149.700.000 -29.79%
2017 287.400.000 47.91%
2018 243.300.000 -18.13%
2019 239.300.000 -1.67%
2020 36.500.000 -555.62%
2021 25.800.000 -41.47%
2022 229.600.000 88.76%
2023 852.400.000 73.06%
2023 504.200.000 -69.06%
2024 208.400.000 -141.94%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Calumet Specialty Products Partners, L.P. Gross Profit
Year Gross Profit Growth
2001 34.237.000
2002 47.439.000 27.83%
2003 44.985.000 -5.46%
2004 38.332.000 -17.36%
2005 140.357.000 72.69%
2006 203.244.000 30.94%
2007 181.356.000 -12.07%
2008 253.883.000 28.57%
2009 173.102.000 -46.67%
2010 198.749.000 12.9%
2011 274.130.000 27.5%
2012 513.177.000 46.58%
2013 410.000.000 -25.17%
2014 529.700.000 22.6%
2015 594.600.000 10.91%
2016 408.300.000 -45.63%
2017 498.200.000 18.04%
2018 436.700.000 -14.08%
2019 451.700.000 3.32%
2020 210.100.000 -114.99%
2021 142.900.000 -47.03%
2022 350.800.000 59.26%
2023 1.046.400.000 66.48%
2023 502.300.000 -108.32%
2024 255.200.000 -96.83%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Calumet Specialty Products Partners, L.P. Net Profit
Year Net Profit Growth
2001 -13.284.000
2002 5.281.000 351.54%
2003 -4.931.000 207.1%
2004 8.970.000 154.97%
2005 11.328.000 20.82%
2006 93.882.000 87.93%
2007 82.874.000 -13.28%
2008 44.437.000 -86.5%
2009 60.549.000 26.61%
2010 16.367.000 -269.95%
2011 86.072.000 80.98%
2012 204.538.000 57.92%
2013 3.300.000 -6098.12%
2014 -112.200.000 102.94%
2015 -139.400.000 19.51%
2016 -328.600.000 57.58%
2017 -103.800.000 -216.57%
2018 -55.100.000 -88.38%
2019 -43.600.000 -26.38%
2020 -149.000.000 70.74%
2021 -260.100.000 42.71%
2022 -171.800.000 -51.4%
2023 412.400.000 141.66%
2023 48.100.000 -757.38%
2024 -153.200.000 131.4%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Calumet Specialty Products Partners, L.P. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2001 -13.284
2002 5.281 351.54%
2003 -4.931 207.1%
2004 0 0%
2005 10.195 100%
2006 3 -509650%
2007 3 0%
2008 1 -100%
2009 2 0%
2010 0 0%
2011 1 0%
2012 4 100%
2013 0 0%
2014 -2 100%
2015 -2 0%
2016 -4 75%
2017 -1 -300%
2018 -1 0%
2019 -1 0%
2020 -2 100%
2021 -3 66.67%
2022 -2 -50%
2023 5 140%
2023 1 0%
2024 -2 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Calumet Specialty Products Partners, L.P. Free Cashflow
Year Free Cashflow Growth
2003 7.048.000
2004 -43.645.000 116.15%
2005 -46.964.000 7.07%
2006 90.704.000 151.78%
2007 -93.469.000 197.04%
2008 -37.361.000 -150.18%
2009 77.333.000 148.31%
2010 99.142.000 22%
2011 14.300.000 -593.3%
2012 323.055.000 95.57%
2013 -121.700.000 365.45%
2014 -63.100.000 -92.87%
2015 37.100.000 270.08%
2016 -135.300.000 127.42%
2017 -96.500.000 -40.21%
2018 25.400.000 479.92%
2019 137.000.000 81.46%
2020 18.800.000 -628.72%
2021 -126.900.000 114.81%
2022 -435.600.000 70.87%
2023 13.100.000 3425.19%
2023 -286.700.000 104.57%
2024 51.500.000 656.7%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Calumet Specialty Products Partners, L.P. Operating Cashflow
Year Operating Cashflow Growth
2003 7.048.000
2004 -612.000 1251.63%
2005 -34.001.000 98.2%
2006 166.768.000 120.39%
2007 167.546.000 0.46%
2008 130.341.000 -28.54%
2009 100.854.000 -29.24%
2010 134.143.000 24.82%
2011 63.778.000 -110.33%
2012 380.108.000 83.22%
2013 39.100.000 -872.14%
2014 226.800.000 82.76%
2015 376.400.000 39.74%
2016 4.100.000 -9080.49%
2017 -26.500.000 115.47%
2018 75.200.000 135.24%
2019 191.900.000 60.81%
2020 62.800.000 -205.57%
2021 -44.000.000 242.73%
2022 100.600.000 143.74%
2023 45.200.000 -122.57%
2023 -14.900.000 403.36%
2024 66.500.000 122.41%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Calumet Specialty Products Partners, L.P. Capital Expenditure
Year Capital Expenditure Growth
2003 0
2004 43.033.000 100%
2005 12.963.000 -231.97%
2006 76.064.000 82.96%
2007 261.015.000 70.86%
2008 167.702.000 -55.64%
2009 23.521.000 -612.99%
2010 35.001.000 32.8%
2011 49.478.000 29.26%
2012 57.053.000 13.28%
2013 160.800.000 64.52%
2014 289.900.000 44.53%
2015 339.300.000 14.56%
2016 139.400.000 -143.4%
2017 70.000.000 -99.14%
2018 49.800.000 -40.56%
2019 54.900.000 9.29%
2020 44.000.000 -24.77%
2021 82.900.000 46.92%
2022 536.200.000 84.54%
2023 32.100.000 -1570.4%
2023 271.800.000 88.19%
2024 15.000.000 -1712%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Calumet Specialty Products Partners, L.P. Equity
Year Equity Growth
2001 17.362.000
2002 0 0%
2003 0 0%
2004 34.514.000 100%
2005 39.054.000 11.62%
2006 378.685.000 89.69%
2007 399.644.000 5.24%
2008 473.212.000 15.55%
2009 485.347.000 2.5%
2010 398.279.000 -21.86%
2011 728.900.000 45.36%
2012 920.293.000 20.8%
2013 1.099.400.000 16.29%
2014 840.800.000 -30.76%
2015 631.400.000 -33.16%
2016 234.500.000 -169.25%
2017 133.700.000 -75.39%
2018 4.100.000 -3160.98%
2019 1.400.000 -192.86%
2020 -3.300.000 142.42%
2021 -6.300.000 47.62%
2022 -37.700.000 83.29%
2023 -244.700.000 84.59%
2023 52.400.000 566.98%
2024 -320.800.000 116.33%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Calumet Specialty Products Partners, L.P. Assets
Year Assets Growth
2001 174.756.000
2002 186.947.000 6.52%
2003 189.545.000 1.37%
2004 318.206.000 40.43%
2005 399.717.000 20.39%
2006 530.174.000 24.61%
2007 678.857.000 21.9%
2008 1.081.062.000 37.2%
2009 1.031.856.000 -4.77%
2010 1.016.672.000 -1.49%
2011 1.732.058.000 41.3%
2012 2.253.045.000 23.12%
2013 2.688.100.000 16.18%
2014 3.119.800.000 13.84%
2015 2.944.700.000 -5.95%
2016 2.725.200.000 -8.05%
2017 2.688.800.000 -1.35%
2018 2.087.500.000 -28.8%
2019 1.857.800.000 -12.36%
2020 1.808.300.000 -2.74%
2021 2.127.900.000 15.02%
2022 2.741.800.000 22.39%
2023 2.751.300.000 0.35%
2023 2.804.800.000 1.91%
2024 2.670.900.000 -5.01%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Calumet Specialty Products Partners, L.P. Liabilities
Year Liabilities Growth
2001 174.756.000
2002 186.947.000 6.52%
2003 189.545.000 1.37%
2004 283.692.000 33.19%
2005 360.663.000 21.34%
2006 151.489.000 -138.08%
2007 279.213.000 45.74%
2008 607.850.000 54.07%
2009 546.509.000 -11.22%
2010 618.393.000 11.62%
2011 1.003.158.000 38.36%
2012 1.363.252.000 26.41%
2013 1.625.300.000 16.12%
2014 2.309.600.000 29.63%
2015 2.340.800.000 1.33%
2016 2.506.500.000 6.61%
2017 2.568.900.000 2.43%
2018 2.021.800.000 -27.06%
2019 1.836.200.000 -10.11%
2020 1.936.900.000 5.2%
2021 2.513.000.000 22.92%
2022 3.029.500.000 17.05%
2023 2.996.000.000 -1.12%
2023 3.002.400.000 0.21%
2024 2.991.700.000 -0.36%

Calumet Specialty Products Partners, L.P. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
63.97
Net Income per Share
-0.29
Price to Earning Ratio
-70.96x
Price To Sales Ratio
0.34x
POCF Ratio
160.01
PFCF Ratio
-19.69
Price to Book Ratio
-2.88
EV to Sales
0.75
EV Over EBITDA
9.23
EV to Operating CashFlow
378.36
EV to FreeCashFlow
-43.66
Earnings Yield
-0.01
FreeCashFlow Yield
-0.05
Market Cap
1,74 Bil.
Enterprise Value
3,86 Bil.
Graham Number
6.72
Graham NetNet
-31.34

Income Statement Metrics

Net Income per Share
-0.29
Income Quality
-0.39
ROE
0.05
Return On Assets
-0.01
Return On Capital Employed
0.18
Net Income per EBT
0.84
EBT Per Ebit
-0.1
Ebit per Revenue
0.05
Effective Tax Rate
-0.05

Margins

Sales, General, & Administrative to Revenue
0.03
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.09
Operating Profit Margin
0.05
Pretax Profit Margin
-0.01
Net Profit Margin
-0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.13
Free CashFlow per Share
-1.1
Capex to Operating CashFlow
9.67
Capex to Revenue
0.02
Capex to Depreciation
0.53
Return on Invested Capital
0.18
Return on Tangible Assets
-0.01
Days Sales Outstanding
24.05
Days Payables Outstanding
26.55
Days of Inventory on Hand
30.63
Receivables Turnover
15.17
Payables Turnover
13.75
Inventory Turnover
11.92
Capex per Share
1.22

Balance Sheet

Cash per Share
0,18
Book Value per Share
-3,98
Tangible Book Value per Share
-3.98
Shareholders Equity per Share
-7.03
Interest Debt per Share
27.5
Debt to Equity
-3.71
Debt to Assets
0.79
Net Debt to EBITDA
5.07
Current Ratio
0.65
Tangible Asset Value
-0,32 Bil.
Net Current Asset Value
-2,20 Bil.
Invested Capital
1125700000
Working Capital
-0,42 Bil.
Intangibles to Total Assets
0
Average Receivables
0,34 Bil.
Average Payables
0,33 Bil.
Average Inventory
398950000
Debt to Market Cap
1.21

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Calumet Specialty Products Partners, L.P. Dividends
Year Dividends Growth
2006 1
2007 2 50%
2008 2 -100%
2009 2 0%
2010 2 0%
2011 2 0%
2012 2 50%
2013 3 0%
2014 3 0%
2015 3 0%
2016 1 0%

Calumet Specialty Products Partners, L.P. Profile

About Calumet Specialty Products Partners, L.P.

Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. Its Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The company's Montana/Renewables segment focuses on processing renewable feedstocks into renewable hydrogen, renewable natural gas, renewable propane, renewable naphtha, renewable kerosene/aviation fuel, and renewable diesel. This segment also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. Its Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. Calumet GP, LLC serves as the general partner for Calumet Specialty Products Partners, L.P. The company was founded in 1916 and is headquartered in Indianapolis, Indiana.

CEO
Mr. Louis Todd Borgmann
Employee
1.580
Address
2780 Waterfront Parkway East Drive
Indianapolis, 46214

Calumet Specialty Products Partners, L.P. Executives & BODs

Calumet Specialty Products Partners, L.P. Executives & BODs
# Name Age
1 Mr. Louis Todd Borgmann
President, Chief Executive Officer & Director
70
2 Mr. David Lunin
Executive Vice President & Chief Financial Officer of Calumet GP, LLC
70
3 Mr. Scott Obermeier
Executive Vice President of Specialties of Calumet GP, LLC
70
4 Mr. Vincent Donargo
Chief Accounting Officer & Principal Accounting Officer
70
5 Mr. John Kompa
Director of Investor Relations
70
6 Mr. Gregory J. Morical
Senior Vice President, General Counsel & Secretary of Calumet GP, LLC
70
7 Mr. Bruce A. Fleming
Executive Vice President of Montana Renewables & Corporate Development of Calumet GP, LLC
70
8 Mr. Chris Hodges
Alpha IR
70

Calumet Specialty Products Partners, L.P. Competitors